{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:27:44Z","timestamp":1782296864530,"version":"3.54.5"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02824","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T06:23:24Z","timestamp":1544509404000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["DNA-Mediated Interferon Signature Induction by SLE Serum Occurs in Monocytes Through Two Pathways: A Mechanism to Inhibit Both Pathways"],"prefix":"10.3389","volume":"9","author":[{"given":"Amit","family":"Porat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Giat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Czeslawa","family":"Kowal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoungsun","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eicke","family":"Latz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Ben-Zvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Al-Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE","volume":"8","author":"Tian","year":"2007","journal-title":"Nat Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature08512","article-title":"HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses","volume":"462","author":"Yanai","year":"2009","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J Clin Invest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood-2012-01-401364","article-title":"Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37","volume":"120","author":"Chamilos","year":"2012","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16270","DOI":"10.1073\/pnas.1208796109","article-title":"DEC-205 is a cell surface receptor for CpG oligonucleotides","volume":"109","author":"Lahoud","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0167-4889(00)00087-2","article-title":"The biology of the receptor for advanced glycation end products and its ligands","volume":"1498","author":"Schmidt","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1189\/jlb.1012519","article-title":"RAGE regulation and signaling in inflammation and beyond","volume":"94","author":"Kierdorf","year":"2013","journal-title":"J Leukoc Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.bbamcr.2008.11.016","article-title":"Binding of S100 proteins to RAGE: an update","volume":"1793","author":"Leclerc","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu Rev Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","article-title":"The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system","volume":"270","author":"Hori","year":"1995","journal-title":"J Biol Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1189\/jlb.0409230","article-title":"RAGE: therapeutic target and biomarker of the inflammatory response\u2014The evidence mounts","volume":"86","author":"Ramasamy","year":"2009","journal-title":"J Leukoc Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00541153","article-title":"Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus","volume":"1","author":"Chitrabamrung","year":"1981","journal-title":"Rheumatol Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1515\/cclm-2012-0521","article-title":"Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement","volume":"51","author":"Skiljevic","year":"2013","journal-title":"Clin Chem Lab Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clim.2004.05.009","article-title":"DNaseI in pathogenesis of systemic lupus erythematosus","volume":"113","author":"Tsukumo","year":"2004","journal-title":"Clin Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1186\/ar3332","article-title":"High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus","volume":"13","author":"Abdulahad","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"946748","DOI":"10.1155\/2015\/946748","article-title":"HMGB1 promotes systemic lupus erythematosus by enhancing macrophage inflammatory response","volume":"2015","author":"Lu","year":"2015","journal-title":"J Immunol Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrrheum.2013.75","article-title":"Connective tissue diseases: HMGB1 helps elicit anti-dsDNA antibody production in SLE","volume":"9","author":"Cully","year":"2013","journal-title":"Nat Rev Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.4049\/jimmunol.1101467","article-title":"Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes","volume":"187","author":"Ramsland","year":"2011","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1089\/jir.2011.0071","article-title":"Interferon alpha as a primary pathogenic factor in human lupus","volume":"31","author":"Niewold","year":"2011","journal-title":"J Interferon Cytokine Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","article-title":"Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history","volume":"19","author":"Fitzgerald-Bocarsly","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"934161","DOI":"10.1155\/2012\/934161","article-title":"Tolerogenic versus inflammatory activity of peripheral blood monocytes and dendritic cells subpopulations in systemic lupus erythematosus","volume":"2012","author":"Carvalheiro","year":"2012","journal-title":"Clin Dev Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00296-010-1709-6","article-title":"Functional characterization of peripheral blood dendritic cells and monocytes in systemic lupus erythematosus","volume":"32","author":"Henriques","year":"2012","journal-title":"Rheumatol Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.clim.2008.01.014","article-title":"Human monocytes represent a competitive source of interferon-alpha in peripheral blood","volume":"127","author":"Hansmann","year":"2008","journal-title":"Clin Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.4049\/jimmunol.180.7.5101","article-title":"A novel type I IFN-producing cell subset in murine lupus","volume":"180","author":"Lee","year":"2008","journal-title":"J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1073\/pnas.94.5.1955","article-title":"Peptide inhibition of glomerular deposition of an anti-DNA antibody","volume":"94","author":"Gaynor","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e3347","DOI":"10.1371\/journal.pone.0003347","article-title":"Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus","volume":"3","author":"Fragoso-Loyo","year":"2008","journal-title":"PLoS ONE"},{"key":"B28","first-page":"1553","article-title":"Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus","volume":"33","author":"Hanly","year":"2006","journal-title":"J Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/art.22030","article-title":"Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus","volume":"54","author":"Harrison","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1136\/ard.2004.029280","article-title":"Autoantibodies to a NR2A peptide of the glutamate\/NMDA receptor in sera of patients with systemic lupus erythematosus","volume":"64","author":"Husebye","year":"2005","journal-title":"Ann Rheum Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/art.22031","article-title":"Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus","volume":"54","author":"Lapteva","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1084\/jem.188.1.29","article-title":"Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition","volume":"188","author":"Putterman","year":"1998","journal-title":"J Exp Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/rheumatology\/keg161","article-title":"Studies of human polyclonal and monoclonal antibodies binding to lupus autoantigens and cross-reactive antigens","volume":"42","author":"Sharma","year":"2003","journal-title":"Rheumatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","first-page":"11942","DOI":"10.1073\/pnas.1003893107","article-title":"A critical cysteine is required for HMGB1 binding to toll-like receptor 4 and activation of macrophage cytokine release","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0165-2478(87)90134-9","article-title":"Production and characterization of heat-aggregated IgG complexes with pre-determined molecular masses: light-scattering study","volume":"15","author":"Ostreiko","year":"1987","journal-title":"Immunol Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1177\/0961203310371161","article-title":"The interferon-alpha signature of systemic lupus erythematosus","volume":"19","author":"Obermoser","year":"2010","journal-title":"Lupus"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/art.21893","article-title":"Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA","volume":"54","author":"Lovgren","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1084\/jem.20081165","article-title":"Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE","volume":"205","author":"Urbonaviciute","year":"2008","journal-title":"J Exp Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.4049\/jimmunol.1203301","article-title":"Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2\/microRNA-155 pathway","volume":"190","author":"Wen","year":"2013","journal-title":"J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","article-title":"Type I interferon in systemic lupus erythematosus and other autoimmune diseases","volume":"25","author":"Banchereau","year":"2006","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/cti.2016.26","article-title":"Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway","volume":"5","author":"Oon","year":"","journal-title":"Clin Transl Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/aps.2015.91","article-title":"Toll-like receptors: potential targets for lupus treatment","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol Sin."},{"key":"B44","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nature09102","article-title":"TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus","volume":"465","author":"Guiducci","year":"2010","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/icb.2012.10","article-title":"Role of type I interferons in the activation of autoreactive B cells","volume":"90","author":"Kiefer","year":"2012","journal-title":"Immunol Cell Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/icb.2012.7","article-title":"Modulation of T-cell function by type I interferon","volume":"90","author":"Tough","year":"2012","journal-title":"Immunol Cell Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/art.21553","article-title":"Toll-like receptor 9 signaling protects against murine lupus","volume":"54","author":"Wu","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B48","doi-asserted-by":"publisher","first-page":"R239","DOI":"10.1186\/ar1165","article-title":"Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis","volume":"6","author":"van Holten","year":"2004","journal-title":"Arthritis Res Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/ar598","article-title":"Interferon-beta for treatment of rheumatoid arthritis?","volume":"4","author":"van Holten","year":"2002","journal-title":"Arthritis Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J Exp Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.4049\/jimmunol.178.4.2204","article-title":"Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs","volume":"178","author":"Yarilina","year":"2007","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.4049\/jimmunol.1502169","article-title":"RAGE enhances TLR responses through binding and internalization of RNA","volume":"197","author":"Bertheloot","year":"2016","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1084\/jem.20120201","article-title":"RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA","volume":"210","author":"Sirois","year":"2013","journal-title":"J Exp Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/cdd.2014.40","article-title":"Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis","volume":"21","author":"Xu","year":"2014","journal-title":"Cell Death Differ."},{"key":"B55","doi-asserted-by":"publisher","first-page":"11542","DOI":"10.1073\/pnas.1108535108","article-title":"Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs)","volume":"108","author":"Yanai","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.omtm.2017.05.006","article-title":"Anti-high mobility group Box1 amliorates albuminuria in MRL\/lpr lupus prone mice","volume":"6","author":"Watanabe","year":"2017","journal-title":"Mol Ther Methods Clin Dev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/sji.12165","article-title":"High-mobility group box 1 inhibition alleviates lupus-like disease in BXSB mice","volume":"79","author":"Zhang","year":"2014","journal-title":"Scand J Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02824\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T06:23:27Z","timestamp":1544509407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02824\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2018.02824"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02824","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"article-number":"2824"}}